Nuo Therapeutics, Inc. (AURX): Total Liabilities
$2.80M
As of 2025-12-31
$4.16M
As of 2026-06-30
+48.5%
3-year compound annual growth
+33.3%
5-year compound annual growth
-23.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.80M | +314.7% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $675.8K | -19.4% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $838.7K | -2.0% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $856.0K | +27.2% | 2024-04-19, Balance as of period end |
| 2021-12-31 | $673.1K | n/a | 2023-04-17, Balance as of period end |
| 2021-09-30 | $672.5K | n/a | 2022-04-15, Balance as of period end |
| 2021-06-30 | $668.9K | n/a | 2022-04-15, Balance as of period end |
| 2021-03-31 | $666.5K | n/a | 2022-04-15, Balance as of period end |
| 2020-12-31 | $665.0K | n/a | 2022-04-15, Balance as of period end |
| 2020-09-30 | $1.03M | n/a | 2022-04-15, Balance as of period end |
| 2020-06-30 | $1.02M | n/a | 2022-04-15, Balance as of period end |
| 2020-03-31 | $1.01M | n/a | 2022-04-15, Balance as of period end |
| 2019-12-31 | $1.49M | +40.5% | 2022-04-15, Balance as of period end |
| 2018-12-31 | $1.06M | +12.4% | 2019-04-16, Balance as of period end |
| 2017-12-31 | $941.2K | -40.1% | 2019-04-16, Balance as of period end |
| 2016-12-31 | $1.57M | -96.4% | 2018-04-16, Balance as of period end |
| 2015-12-31 | $43.13M | +7.1% | 2016-10-24, Balance as of period end |
| 2014-12-31 | $40.26M | +107.1% | 2016-10-24, Balance as of period end |
| 2013-12-31 | $19.44M | +207.2% | 2015-03-31, Balance as of period end |
| 2012-12-31 | $6.33M | -6.9% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $6.80M | -24.3% | 2013-03-18, Balance as of period end |
| 2010-12-31 | $8.98M | n/a | 2012-03-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | $2.80M | +314.7% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $44.20M | +38.0% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $5.72M | +47.7% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $546.1K | -77.3% |
| Intelligent Bio Solutions Inc. (INBS) | 2026-06-30 | $6.65M | +22.4% |
| Lucid Diagnostics Inc. (LUCD) | 2025-12-31 | $29.51M | +16.5% |
| Femasys Inc (FEMY) | 2025-12-31 | $14.85M | +46.5% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $18.76M | -47.7% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $12.33M | -20.9% |
Compare AURX, OSRH, TNON, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗